Search

everythinglearnresearchcommunity

for

Search:↓

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Low iron levels are significantly linked to hair loss in women.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Nourkrin® Woman with Marilex® improves hair growth, appearance, and confidence in women with hair loss.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Review finds no permanent solution for female hair loss.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Hair loss linked to higher heart disease risk in both men and women.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Platelet-rich plasma (PRP) may help with various hair loss types, but more research is needed to find the best use method.

BeauTop improves hair growth in androgenetic alopecia patients.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Finasteride helps hair growth but stopping it causes faster hair loss.

t-Flavanone helps improve male pattern hair loss by making hair roots stronger.

Eating a balanced diet with specific nutrients is important for menopausal women to manage hair loss.

Kenogen increases with hair loss in women.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Use minoxidil for hair loss treatment; assess results after 6 months.